chevron_leftBack
As of 6 June 2026, G&E Herbal Biotechnology Co., Ltd. has a market cap of $71.2M USD, ranking #27995 globally and #1619 in Taiwan.
It ranks #2528 in the Healthcare sector, and #907 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$71.2MUSD
2.24B TWD
Enterprise Value
$57.55MUSD
1.81B TWD
Revenue (TTM)
$9.83MUSD
309.13M TWD
EBITDA (TTM)
$5.15MUSD
162.03M TWD
Net Income (TTM)
$4.43MUSD
139.2M TWD
EBITDA Margin
52%
Profit Margin
45%
PE Ratio
16.1
PS Ratio
7.2
PB Ratio
2.4
EV/EBITDA
11.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Kou-Wha Kou
open_in_new
Employees
39
Founded
2002
Website
geherbs.com.tw
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.7% | -2.6% | 0.7% | -16% | -29% | -30% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
4911
德英生物科技股份有限公司
ISIN: TW0004911003
Shares Out.:
Shares Outstanding:
63.72M1
Shares Float:
48.06M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
34.55 TWD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About G&E Herbal Biotechnology Co., Ltd.
G&E Herbal Biotechnology Co., Ltd. engages in manufacturing and wholesale of western and chinese medicine, cosmetics, intellectual property rights, biotechnology services, medical device, and other unclassified food products in Taiwan. It offers HepaGent capsules, a liver protective agent; botanical food supplements; botanical anti-aging cosmetics, such as facial cleansing essence, botanic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; as well as lubricants. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TWSE: 6446
|
$7.8B
11K%
245.34B TWD
|
48.6
|
|
TWSE: 1795
|
$1.84B
2K%
57.95B TWD
|
12.2
|
|
TPEX: 4123
|
$925.55M
1K%
29.11B TWD
|
3.4
|
|
TPEX: 6535
|
$809.3M
1K%
25.46B TWD
|
-
|
|
TPEX: 4743
|
$789.12M
1K%
24.82B TWD
|
-
|
|
TPEX: 4105
|
$584.14M
720%
18.38B TWD
|
11.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
1M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
769K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
506K%
|
97.4
|
|
SIX: RO
|
$324.68B
456K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.43B
406K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$277.35B
389K%
218.9B CHF
|
20.5
|
chevron_leftBack